Medicines and Related Substances Act, 1965
R 385
Subregulation (8) Method 2: Internal models approach |
Subregulation (8)(c) Qualitative requirements
Subregulation (8)(d) Matters relating to the specification of relevant market risk factors
Subregulation (8)(f) Specific matters relating to stress testing
Subregulation (8)(g) Matters relating to external validation
Subregulation 8(h) Matters specifically related to the treatment of specific risk
